期刊
NATURE
卷 502, 期 7472, 页码 480-488出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature12751
关键词
-
资金
- Danish National Research Foundation
- Danish Cancer Society
- Novo Nordisk Foundation
- Lundbeck Foundation
- European Union
- European Research Council
- Excellence Programme of the University of Copenhagen
A plethora of groundbreaking studies have demonstrated the importance of chromatin-associated proteins and post-translational modifications of histones, proteins and DNA (so-called epigenetic modifications) for transcriptional control and normal development. Disruption of epigenetic control is a frequent event in disease, and the first epigenetic-based therapies for cancer treatment have been approved. A generation of new classes of potent and specific inhibitors for several chromatin-associated proteins have shown promise in preclinical trials. Although the biology of epigenetic regulation is complex, new inhibitors such as these will hopefully be of clinical use in the coming years.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据